Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Schulman

Showing results (21-30 of 424) with videos related to

Pageof 43
Sort By:
Current Opinion in Pulmonary Medicine|July 27, 2000
Duration of anticoagulants in acute or recurrent venous thromboembolismS Schulman
Lakartidningen|January 5, 2002
[Cure of hemophilia is approaching. Gene therapy is the hope]S Schulman
Lakartidningen|June 30, 2001
[Children with mentally disabled parents--invisible but with extensive needs]S Schulman
Transfusion Medicine Reviews|April 1, 1991
DDAVP--the multipotent drug in patients with coagulopathiesS Schulman
Annals of Hematology|September 1, 1991
Effects of factor VIII concentrates on the immune system in hemophilic patientsS Schulman
Journal of Thrombosis and Haemostasis : JTH|August 2, 2007
Thrombophilia and location of venous thromboembolismS Schulman
Journal of Internal Medicine|October 12, 2013
Advantages and limitations of the new anticoagulantsS Schulman
Journal of the Royal Society of Medicine|November 1, 1996
Anticoagulation in venous thrombosisS Schulman
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 5, 1999
Safety, efficacy and lessons from continuous infusion with rFVIIa. rFVIIa-CI GroupS Schulman
Haemostasis|March 9, 1999
Long-term prophylaxis in venous thromboembolism: LMWH or oral anticoagulation?S Schulman
Pageof 43

Showing results (21-30 of 424) with videos related to

Sort By:
Pageof 43
Current Opinion in Pulmonary Medicine|July 27, 2000
Duration of anticoagulants in acute or recurrent venous thromboembolismS Schulman
Lakartidningen|January 5, 2002
[Cure of hemophilia is approaching. Gene therapy is the hope]S Schulman
Lakartidningen|June 30, 2001
[Children with mentally disabled parents--invisible but with extensive needs]S Schulman
Transfusion Medicine Reviews|April 1, 1991
DDAVP--the multipotent drug in patients with coagulopathiesS Schulman
Annals of Hematology|September 1, 1991
Effects of factor VIII concentrates on the immune system in hemophilic patientsS Schulman
Journal of Thrombosis and Haemostasis : JTH|August 2, 2007
Thrombophilia and location of venous thromboembolismS Schulman
Journal of Internal Medicine|October 12, 2013
Advantages and limitations of the new anticoagulantsS Schulman
Journal of the Royal Society of Medicine|November 1, 1996
Anticoagulation in venous thrombosisS Schulman
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 5, 1999
Safety, efficacy and lessons from continuous infusion with rFVIIa. rFVIIa-CI GroupS Schulman
Haemostasis|March 9, 1999
Long-term prophylaxis in venous thromboembolism: LMWH or oral anticoagulation?S Schulman
Pageof 43